GSK closes Bangladesh manufacturing, cuts 1,000 workers

GSK in 2017 announced a revamp of its emerging markets operations to make them more efficient. (Eric Saganowsky)

GlaxoSmithKline has been remaking its emerging markets operations to be more efficient and cost effective and a manufacturing plant and 1,000 employees in Bangladesh are the next to be streamlined into extinction.

The U.K. drugmaker confirmed Friday it will close the outdated facility and layoff the 1,000 manufacturing and commercial operations employees by the end of the year.